Archive | Biopharmaceuticals

Momentum Market Ignores Washington- Biotech Sector Hits New Highs

source link FED Fuel Fans Feuer The monetized momentum market rolled on today despite the backdrop of bearish commentary from celebrity pundits and strategists. With the DOW hitting new highs at 14,263 (and forgetting about the 2001 NASDAQ 5000 high which is still 2000 points away),  growth in the ISM at 56 showing expansion, and China growth pegged […]

Continue Reading 0

Life Science Stocks Perky Today: ACHN,ALXN, AMRI,CBST,PCYC,OPTR

follow link Biotech Rally Takes Sector to New Highs After a brief lull many biopharmaceuticals stocks are rallying over 2% today. Recently we reiterated Cubist (CBST $45.38) up 4.4% and Optimer (OPTR $12.62) up 3.34% and both are among big movers today. Taking the lead from some undiscovered small to mid cap stocks which have recently taken […]

Continue Reading 0

Rayno Biopharmaceutical Portfolio Performance- After Sell-Off 2/26/13

buy pfizer Lyrica online  Caution-Follow Technicals-Potential for Macro Risk Off The Life Science sector is about 2% off highs of February 1 and has formed a double top from October 5 highs. In recent posts we urged caution as some MO stocks had blow-off tops (ALXN,MDVN, REGN) and the IBB and XBI were unable to reach new highs with […]

Continue Reading 0

Biotech Stocks Rally After Brief Sell-Off: INFI, PCYC Update-1 2/25

Technicals Still Rule As Momentum Eases-Reiterate Caution MO favs down:  INFI, MDVN, PCYC The Life Science sector is up about 1% after two days of selling on heavy volume. The bellwether ETFs (IBB $145.16)  are about 2% off 52 week highs and we do not expect this rally to surpass highs so caution is still […]

Continue Reading 0

MO Money Moves On to Infinity Pharmaceuticals (INFI $41.10)Up 16%

The BIG money in biotech has moved on to new names like Infinity (INFI) up 15 points since December. In the meantime they are moving out of the big winners from 2012 like Alexion (ALXN  $83.4) down 3% and Regeneron (REGN $160) down 2.7% . See previous postings. The tremendous liquidity in this market can […]

Continue Reading 0

Rayno Biopharmaceutical Focus Stocks: Ones to Watch -ALXN,PCYC,REGN

Caution is Warranted by Technicals Given the toppiness in the biotechnology sector and the stalling of the IBB ($146), it looks like momentum is waning and some MO stocks favored by BIG money are selling off. Nonetheless we have not made any portfolio recommendations other than raising a little cash. We will update if there is […]

Continue Reading 0

Market Grinds Up- With Profit Taking In Some Biotech MO Stocks

Sell-Off Evident In Big Winners-Technicals Are Very Important In Here The 2013 rally trickled up today with the DOW and S&P up, but off its highs. NASDAQ is flat. The media trash talk has stoked up with many well known pundits and strategists urging caution but others repeating the worn mantra “don’t fight the tape, […]

Continue Reading 0

Bull Run Gets A Second Wind on A Frantic Friday: Many Life Science Stocks Are At All Time Highs

Dow 14,000 and General Market Euphoria Lifts All Stocks: Has the Bond Bubble Burst? Life Science stocks ran with the general market today and with all the green screens you’d think it was St. Paddy’s Day. The concern now is that everybody is bullish and think equities is the place to be invested. European crises […]

Continue Reading 0

Genomics Heats Up With LIFE Technologies Play

Future Clinical Potential of Genomics Attracts Financing and Deals Life Technologies (LIFE $65) was up 3.6% again today on news that ThermoFisher (TMO $71.51) is studying a takeover. The market cap of LIFE is $10.7B while that of ThermoFisher is $25B. Private equity firms are also looking at LIFE which is up 34% YTD. ThermoFisher […]

Continue Reading 0

Biotech Bull Market Rolls Merrily Along- Funds Are the Engine

Bullish Mentality Drives Usual MO-vers: PCYC, MDVN, REGN, SGEN  It is hard to add biotech stocks to your portfolio at these elevated levels but big players like Fidelity, Cap World, JPMorgan, T.Rowe Price and selected hedge funds- Orbimed, Baker Bros, etc can drive their holdings up more on any good news. Case in point is […]

Continue Reading 0